Abstract:In order to achieve the passive tumor targeting and acid-triggered drugs release in lysosomes, optimized delivery system for doxorubicin based on pH-sensitive complex nanomicelles with suitable particle size was developed in this research. Particularly, poly(L-succinimide) was thoroughly ring-opened by ethylenediamine to give the poly(N-(2-aminoethyl)-L-aspartamide). Then, graft copolymer mPEG-graft-poly(N-(2-aminoethyl)-L-aspartamide)-hexahydrophthalic acid (mPEG-g-P(ae-Asp)-Hap) was synthesized by grafting mPEG-2000 and hexahydrophthalic anhydride onto poly(N-(2-aminoethyl)-L-aspartamide). In vitro studies revealed that mPEG-g-P(ae-Asp)-Hap copolymer was stable in neutral solutions but tend to be hydrolyzed under acidic condition, which was attributed to the acid-sensitive properties of hexahydrophthalic amides (β-carboxylic amides). MPEG-g-P(ae-Asp)-Hap copolymer with critical aggregation concentration of 0.166 mg·mL−1 could self-assemble into stable blank nanomicelles with an average particle hydrodynamic diameter of 98.1 nm, but the hydrodynamic diameter of doxorubicin-loaded nanomicelles (mPEG-g-P(ae-Asp)-Hap·Dox) was smaller and approximately 77.5 nm. MPEG-g-P(ae-Asp)-Hap·Dox nanomicelles showed sustained drug release profiles over 34 h, and the cumulative drug release showed a tendency to increase from 25% to 62% with the pH value decreasing from 7.4 to 5.0 due to the acid-triggered disassembly of nanomicelles. The cytotoxicity of mPEG-g-P(ae-Asp)-Hap·Dox nanomicelles against A549 treated with 40 mM NH4Cl (lysosomotropic weak bases) was decreased significantly than that without NH4Cl treatment, further confirmed the drug release from the nanomicelles was triggered by the low pH value of lysosome (pH 5.0). Compared with doxorubicin HCl, mPEG-g-P(ae-Asp)-Hap·Dox nanomicelle drug showed enhanced cellular uptake ability during 2 or 4 h of incubation due to the endocytosis mechanism of nanomicelle drug. In summary, the cleavage of pH-sensitive β-carboxylic amides bonds on the hydrophobic branch of mPEG-g-P(ae-Asp)-Hap copolymer triggered the disassembly of the nanomicelles and release of doxorubicin in the acidic lysosomal compartments of cancer cells. These nanomicelles exhibited excellent potential for drug delivery due to their smart properties-PEGylation, suitable size, and acid-triggered drug release.

Crgd Targeted and Charge Conversion-Controlled Release Micelles for Doxorubicin Delivery

Crgdyk Modified Ph Responsive Nanoparticles for Specific Intracellular Delivery of Doxorubicin.

Crgd-Modified Benzimidazole-based Ph-Responsive Nanoparticles for Enhanced Tumor Targeted Doxorubicin Delivery.

Surface charge-reversible polyelectrolyte complex nanoparticles for hepatoma-targeting delivery of doxorubicin.

Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.

Construction of Small-Sized, Robust, and Reduction-Responsive Polypeptide Micelles for High Loading and Targeted Delivery of Chemotherapeutics

Novel RGD-decorated micelles loaded with doxorubicin for targeted breast cancer chemotherapy

Crgd-Functionalized Polymer Micelles for Targeted Doxorubicin Delivery

Integrin-Targeted Zwitterionic Polymeric Nanoparticles with Acid-Induced Disassembly Property for Enhanced Drug Accumulation and Release in Tumor

Targeted Sustained Delivery of Antineoplastic Agent with Multicomponent Polylactide Stereocomplex Micelle.

Facile Preparation of Core Cross-Linked Nanomicelles Based on Graft Copolymers with Ph Responsivity and Reduction Sensitivity for Doxorubicin Delivery.

Hybrid polymer micelles capable of cRGD targeting and pH-triggered surface charge conversion for tumor selective accumulation and promoted uptake.

Ph-Responsive Polymeric Micelles Based on Poly(2-Ethyl-2-oxazoline)-poly(d,l-lactide) for Tumor-Targeting and Controlled Delivery of Doxorubicin and P-glycoprotein Inhibitor

pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy

Crgd Mediated Redox and Ph Dual Responsive Poly(amidoamine) Dendrimer-Poly(ethylene Glycol) Conjugates for Efficiently Intracellular Antitumor Drug Delivery.

Targeted delivery by pH-responsive mPEG-S-PBLG micelles significantly enhances the anti-tumor efficacy of doxorubicin with reduced cardiotoxicity

Grafted Copolymer Micelles with Ph Triggered Charge Reversibility for Efficient Doxorubicin Delivery

Nanomicelle Drug with Acid-Triggered Doxorubicin Release and Enhanced Cellular Uptake Ability Based on Mpeg-Graft-poly(n-(2-aminoethyl)-l-aspartamide)-hexahydrophthalic Acid Copolymers.

Zwitterionic Nanoparticles Constructed with Well-Defined Reduction-Responsive Shell and Ph-Sensitive Core for “spatiotemporally Pinpointed” Drug Delivery

Enhanced Targeted Delivery of Doxorubicin Based on Acid Induced Charge Reversal and Combinational Stimuli‐Responsive Nanocarrier

Poly(2-(diethylamino)ethyl Methacrylate)-Based, Ph-Responsive, Copolymeric Mixed Micelles for Targeting Anticancer Drug Control Release